Indications for ULTRAVATE:
Apply a thin layer to affected areas 1–2 times daily; max 50 g/week and 2 consecutive weeks' treatment per course. Discontinue when control is achieved. Do not occlude.
Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis, rosacea, perioral dermatitis, or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Treat infection if present; discontinue if infection persists or worsens. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Burning, stinging, itching, dry skin, erythema, skin atrophy, leukoderma, vesicles, rash, pustulation, acne, secondary infections, telangiectasia, urticaria, miliaria; HPA axis suppression (esp. in children).